Panacea Biotec Hits Upper Circuit on Securing UNICEF Vaccine Contract
Panacea Biotec shares reached the upper circuit limit of 5 percent on December 26 after the company received a Letter of Award (LoA) from UNICEF. The award is for supplying 115 million doses of its bivalent oral polio vaccine (bOPV). This significant contract is valued at approximately USD 14.95 million (around Rs 127 crore) and […]
Panacea Biotec Hits Upper Circuit on Securing UNICEF Vaccine Contract Read More »









